The role of peroxiredoxins in cancer

Por Nicolussi, Arianna, D'Inzeo, Sonia, Capalbo, Carlo, Giannini, Giuseppe, Coppa, Anna
Publicado no Mol Clin Oncol (2017)

HER2-positive male breast cancer: an update

Por Ottini, Laura, Capalbo, Carlo, Rizzolo, Piera, Silvestri, Valentina, Bronte, Giuseppe, Rizzo, Sergio, Russo, Antonio
Publicado em 2010

Vemurafenib and panitumumab combination tailored therapy in BRAF-mutated metastatic colorectal cancer: A case report

Por Capalbo, Carlo, Marchetti, Paolo, Coppa, Anna, Calogero, Antonella, Anastasi, Emanuela, Buffone, Amelia, Belardinilli, Francesca, Gulino, Matteo, Frati, Paola, Catalano, Carlo, Cortesi, Enrico, Giannini, Giuseppe, Gulino, Alberto
Publicado em 2014

microRNA-17-92 cluster is a direct Nanog target and controls neural stem cell through Trp53inp1

Por Garg, Neha, Po, Agnese, Miele, Evelina, Campese, Antonio Francesco, Begalli, Federica, Silvano, Marianna, Infante, Paola, Capalbo, Carlo, De Smaele, Enrico, Canettieri, Gianluca, Di Marcotullio, Lucia, Screpanti, Isabella, Ferretti, Elisabetta, Gulino, Alberto
Publicado em 2013

High-throughput microRNA profiling of pediatric high-grade gliomas

Por Miele, Evelina, Buttarelli, Francesca Romana, Arcella, Antonella, Begalli, Federica, Garg, Neha, Silvano, Marianna, Po, Agnese, Baldi, Caterina, Carissimo, Giuseppe, Antonelli, Manila, Spinelli, Gian Paolo, Capalbo, Carlo, Donofrio, Vittoria, Morra, Isabella, Nozza, Paolo, Gulino, Alberto, Giangaspero, Felice, Ferretti, Elisabetta
Publicado em 2014

Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma

Por Coni, Sonia, Mancuso, Anna Barbara, Di Magno, Laura, Sdruscia, Giulia, Manni, Simona, Serrao, Silvia Maria, Rotili, Dante, Spiombi, Eleonora, Bufalieri, Francesca, Petroni, Marialaura, Kusio-Kobialka, Monika, De Smaele, Enrico, Ferretti, Elisabetta, Capalbo, Carlo, Mai, Antonello, Niewiadomski, Pawel, Screpanti, Isabella, Di Marcotullio, Lucia, Canettieri, Gianluca
Publicado no Sci Rep (2017)

Corrigendum: Selective targeting of HDAC1/2 elicits anticancer effects through Gli1 acetylation in preclinical models of SHH Medulloblastoma

Por Coni, Sonia, Mancuso, Anna Barbara, Di Magno, Laura, Sdruscia, Giulia, Manni, Simona, Serrao, Silvia Maria, Rotili, Dante, Spiombi, Eleonora, Bufalieri, Francesca, Petroni, Marialaura, Kusio-Kobialka, Monika, De Smaele, Enrico, Ferretti, Elisabetta, Capalbo, Carlo, Mai, Antonello, Niewiadomski, Pawel, Screpanti, Isabella, Di Marcotullio, Lucia, Canettieri, Gianluca
Publicado no Sci Rep (2017)